Wilson Sonsini is pleased to support Stanford’s Drug Discovery Symposium. Advances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of participants to cover a broad range of policy, research, and venture topics. This symposium provides an invaluable forum for interdisciplinary exchange at the forefront of drug research.
Lori Doyle
ldoyle@wsgr.comVern has three decades of experience formulating successful strategies for innovative life science companies and helping them develop IP programs.